Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms

Area of Science:

• Pulmonary Medicine
• Transplantation Immunology
• Allograft Pathology

Background:

• Chronic lung allograft dysfunction (CLAD) is a primary cause of long-term graft loss after lung transplantation.
• CLAD manifests as two main clinical phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS).
• Understanding the underlying immunologic mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To review the clinical features, diagnostic difficulties, and therapeutic strategies for CLAD.
• To explore the immunologic pathways driving BOS and RAS.
• To identify critical research gaps for improving long-term lung allograft survival.

Main Methods:

• Literature review and synthesis of current research on CLAD.
• Discussion of established and emerging diagnostic criteria.
• Analysis of preclinical and clinical models of CLAD.

Main Results:

• CLAD is characterized by progressive, largely irreversible lung allograft dysfunction.
• BOS and RAS represent distinct clinical and potentially immunological entities within CLAD.
• Current therapeutic options for CLAD are limited, highlighting the need for novel approaches.

Conclusions:

• CLAD remains a major obstacle to successful long-term lung transplantation.
• Further research into the immunobiology of CLAD is essential for targeted therapies.
• Addressing knowledge gaps is critical for improving patient outcomes and graft longevity.